| MolName | (5Z)-3-benzyl-5-[[2-(4-benzylpiperidin-1-yl)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one |
| MolecularFormula | C31H28N4O2S2 |
| Smiles | O=C(/C(/S1)=C/C2=C(N3CCC(Cc4ccccc4)CC3)N=C(C=CC=C3)N3C2=O)N(Cc2ccccc2)C1=S |
| InChI | InChI=1S/C31H28N4O2S2/c36-29-25(20-26-30(37)35(31(38)39-26)21-24-11-5-2-6-12-24)28(32-27-13-7-8-16-34(27)29)33-17-14-23(15-18-33)19-22-9-3-1-4-10-22/h1-13,16,20,23H,14-15,17-19,21H2 |
| InChIK | HHUJXZLGWHKNPM-UHFFFAOYSA-N |
| TotalMolweight | 552.721 |
| Molweight | 552.721 |
| MonoisotopicMass | 552.165366 |
| CLogP | 3.7936 |
| CLogS | -6.664 |
| H Acceptors | 6 |
| TotalSurfaceArea | 414.28 |
| Relative PSA | 0.22625 |
| PolarSurfaceArea | 113.61 |
| Druglikeness | 7.042 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB |
| Shape Index | 0.51282 |
| Fragments | 1 |
| Non HAtoms | 39 |
| NonCHAtoms | 8 |
| Electronegative Atoms | 8 |
| Rotatable Bond | 6 |
| Rings Closures | 6 |
| Small Rings | 6 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 12 |
| Sp3Atoms | 9 |
| Symmetricatoms | 6 |
| Amides | 2 |
| BasicNitrogens | 1 |
| StereoCon |
Click to Load Molecule:
1 - (5Z)-3-benzyl-5-[[2-(4-benzylpiperidin-1-yl)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one | 2 - (5Z)-3-benzyl-5-[[2-(4-benzylpiperidin-1-yl)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one